why Lexicon Pharmaceuticals Inc [LXRX] is a Good Choice for Investors After New Price Target of $5.35
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] slipped around -0.04 points on Thursday, while shares priced at $0.77 at the close of the session, down -4.42%. Compared to the average trading volume of 3.16M shares, LXRX reached a trading volume of 3627850 in the most recent trading